Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)

SHE:301281 Revenue

Shandong Keyuan Pharmaceutical had revenue of 116.66M CNY in the quarter ending June 30, 2025, with 28.39% growth. This brings the company's revenue in the last twelve months to 454.44M, down -1.26% year-over-year. In the year 2024, Shandong Keyuan Pharmaceutical had annual revenue of 463.72M with 3.60% growth.

• Revenue (ttm): 454.44M
• Revenue Growth: -1.26%
• P/S Ratio: 8.46
• Revenue / Employee: 652.93K
• Employees: 696
• Market Cap: 3.85B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	463.72M	16.13M	3.60%
Dec 31, 2023	447.58M	4.72M	1.07%
Jan 1, 2023	442.87M	21.98M	5.22%
Jan 1, 2022	420.89M	53.83M	14.67%
Dec 31, 2020	367.06M	56.05M	18.02%